Pancreatic carcinoma is one of the most challenging cancers to treat, but ongoing advances in medicine offer a spectrum of options from proven standard therapies to experimental approaches being tested in clinical trials around the world.

How Treatment Approaches Help Patients Fight Pancreatic Carcinoma

When someone receives a diagnosis of pancreatic carcinoma, the primary goal of treatment is to remove the cancer if possible, slow its progression, manage symptoms, and maintain the best possible quality of life. The treatment plan depends heavily on where the cancer is located in the pancreas, how large the tumor has grown, whether it has spread to nearby blood vessels or distant organs, and the patient’s overall health and ability to tolerate different therapies.^[4]

Pancreatic cancer is particularly difficult because it often does not cause noticeable symptoms until it has reached an advanced stage. By the time many patients are diagnosed, the cancer may have already spread beyond the pancreas, making surgical removal impossible. This is why only about 20% of patients have cancer that can be surgically removed at the time of diagnosis.^[5]

The medical community recognizes standard treatments that have been proven effective through years of research and clinical experience. These are recommended by medical societies and used in hospitals worldwide. At the same time, researchers are actively testing new drugs and treatment combinations in clinical trials, which are carefully designed studies that evaluate whether experimental therapies are safe and effective. Clinical trials represent hope for better outcomes and give patients access to cutting-edge treatments before they become widely available.^[13]

Standard Treatment Options for Pancreatic Carcinoma

Standard treatment for pancreatic carcinoma varies depending on whether the cancer can be surgically removed. Surgery is the only treatment currently available that offers the possibility of cure. However, even when surgery is performed, many patients require additional treatments to reduce the risk of the cancer returning.^[10]

Surgery for Pancreatic Cancer

The type of surgery depends on where the tumor is located within the pancreas. The most common procedure is called pancreaticoduodenectomy, also known as the Whipple procedure. This is typically used when the cancer is in the head of the pancreas. During this operation, surgeons remove the head of the pancreas, part of the small intestine, the gallbladder, part of the bile duct, and sometimes a portion of the stomach. The remaining organs are then reconnected so that digestion can continue.^[10]

When cancer is located in the tail or body of the pancreas, a distal pancreatectomy may be performed. This surgery removes the tail and body of the pancreas, and often the spleen as well. In some cases, if cancer is widespread throughout the pancreas, a total pancreatectomy may be necessary, which removes the entire pancreas along with connected organs. After a total pancreatectomy, patients develop diabetes because their body no longer produces insulin, and they need to take pancreatic enzymes to help with digestion.^[15]

Surgical resection is a major operation that comes with risks such as bleeding, infection, and complications related to reconnecting the digestive organs. Recovery can take several weeks to months. At specialized, high-volume centers, surgeons have more experience performing these complex procedures, which has been shown to improve outcomes and reduce complications.^[15]

Chemotherapy in Standard Treatment

Chemotherapy uses drugs that kill rapidly dividing cancer cells or stop them from growing. In pancreatic cancer, chemotherapy plays a crucial role both after surgery and when surgery is not an option. After surgical removal of the tumor, chemotherapy is often given as adjuvant therapy to destroy any remaining cancer cells that might be too small to detect. This helps reduce the chance of the cancer coming back.^[13]

Common chemotherapy drugs used for pancreatic cancer include gemcitabine, which interferes with the cancer cell’s ability to replicate its DNA, and combinations such as FOLFIRINOX, which includes four different drugs: folinic acid, fluorouracil, irinotecan, and oxaliplatin. These combinations work through different mechanisms to attack cancer cells more effectively than single drugs alone.^[13]

Chemotherapy is typically given in cycles, with periods of treatment followed by rest periods to allow the body to recover. The duration of treatment varies depending on the stage of cancer and how well the patient tolerates the therapy. Treatment may continue for several months.^[11]

Side effects of chemotherapy can include fatigue, nausea and vomiting, loss of appetite, changes in taste, mouth sores, hair loss, and increased risk of infection due to low white blood cell counts. Some drugs, like oxaliplatin, can cause peripheral neuropathy, which is numbness or tingling in the hands and feet. These side effects usually improve after treatment ends, though some may persist longer.^[13]

Radiation Therapy

Radiation therapy uses high-energy beams to damage the DNA of cancer cells, causing them to die. In pancreatic cancer, radiation is sometimes used before surgery to shrink tumors or after surgery to kill any remaining cancer cells in the area. It can also be used to relieve pain and other symptoms when the cancer cannot be removed.^[11]

Radiation is often given five days a week for several weeks. Each treatment session lasts only a few minutes, though setup and positioning take longer. Radiation therapy is usually combined with chemotherapy, which can make the cancer cells more sensitive to radiation. This combination is called chemoradiation.^[15]

Common side effects of radiation therapy to the abdomen include fatigue, skin irritation in the treated area, nausea, diarrhea, and loss of appetite. These effects are usually temporary and gradually improve after treatment ends. The medical team can prescribe medications to help manage these side effects and maintain nutrition during treatment.^[13]

Treatment Being Tested in Clinical Trials

Clinical trials are research studies designed to test whether new treatments are safe and effective. They represent the pathway through which all new cancer treatments must pass before they can be approved for general use. For pancreatic cancer patients, clinical trials offer access to promising new therapies that are not yet available outside of research settings.^[13]

Understanding Clinical Trial Phases

Clinical trials proceed through distinct phases, each designed to answer specific questions. Phase I trials test a new drug in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. These trials help researchers understand how the human body processes the drug and what dose can be given safely.^[13]

Phase II trials involve larger groups of patients and focus on whether the drug is effective against the cancer. Researchers closely monitor how tumors respond to the treatment and continue to evaluate safety. If a drug shows promise in Phase II, it moves forward to Phase III.^[13]

Phase III trials compare the new treatment to the current standard treatment to determine whether it is more effective, has fewer side effects, or offers other advantages. These trials involve hundreds or thousands of patients and are conducted at multiple hospitals and cancer centers. Successful Phase III trials can lead to approval by regulatory agencies, making the treatment available to all patients.^[13]

Immunotherapy Approaches

Immunotherapy is a type of treatment that helps the body’s own immune system recognize and attack cancer cells. The immune system normally protects us from infections and disease, but cancer cells can hide from immune detection. Immunotherapy drugs work by removing the brakes on the immune system or by teaching immune cells to recognize cancer.^[12]

One type of immunotherapy being tested for pancreatic cancer involves drugs called checkpoint inhibitors. These drugs block proteins that prevent immune cells from attacking cancer. Some patients with pancreatic cancer have genetic changes that make their tumors more likely to respond to checkpoint inhibitors. Researchers are studying whether these drugs can help patients whose tumors have specific genetic features.^[12]

Another approach involves cancer vaccines, which are designed to train the immune system to recognize specific proteins found on pancreatic cancer cells. Unlike vaccines that prevent disease, cancer vaccines are given after diagnosis to help the body fight existing cancer. Several cancer vaccines are being tested in clinical trials, with researchers measuring whether they can help prevent cancer from returning after surgery.^[12]

Targeted Therapy and Precision Medicine

Targeted therapy refers to drugs designed to attack specific molecules or pathways that cancer cells need to grow and survive. Unlike chemotherapy, which affects all rapidly dividing cells, targeted therapies are designed to be more selective, potentially causing fewer side effects on normal cells.^[12]

Researchers have identified several important molecular pathways in pancreatic cancer. One significant discovery involves mutations in a gene called KRAS, which is present in about 90% of pancreatic cancers. For many years, this mutation was considered impossible to target with drugs. However, recent breakthroughs have led to the development of drugs that can block the activity of specific KRAS mutations. These drugs are now being tested in clinical trials for pancreatic cancer patients whose tumors have these specific genetic changes.^[12]

Other targeted therapies focus on blocking growth factor receptors on cancer cells or interfering with the blood vessels that supply tumors with nutrients. Some drugs target the DNA repair mechanisms that cancer cells use to fix damage caused by chemotherapy or radiation. By blocking these repair processes, targeted drugs can make cancer cells more vulnerable to other treatments.^[12]

Innovative Drug Combinations

Clinical trials are testing new combinations of drugs that work through different mechanisms. The goal is to attack cancer cells in multiple ways simultaneously, making it harder for them to develop resistance. For example, researchers are combining chemotherapy with immunotherapy, or targeted therapy with checkpoint inhibitors, to see if these combinations produce better outcomes than single treatments.^[12]

Some trials are investigating whether adding drugs that modify the tumor environment can help other treatments work better. Pancreatic tumors are surrounded by dense tissue that can act as a barrier, preventing chemotherapy and immune cells from reaching the cancer. Drugs that break down this barrier or change the environment around the tumor are being tested to see if they can improve the effectiveness of other treatments.^[12]

Advanced Radiation Techniques

New radiation therapy techniques are being studied in clinical trials. Stereotactic body radiation therapy (SBRT) delivers very high doses of radiation with extreme precision in just a few treatment sessions rather than many weeks. This approach may be especially useful for tumors that are difficult to remove surgically. Clinical trials are evaluating whether SBRT combined with chemotherapy can provide better outcomes with fewer side effects than conventional radiation.^[15]

Who Can Participate in Clinical Trials

Clinical trials have specific requirements about who can participate, called eligibility criteria. These may include the stage and type of cancer, previous treatments received, overall health status, and specific genetic features of the tumor. Some trials are only open to patients who have not yet received treatment, while others are specifically for patients whose cancer has returned after initial therapy.^[13]

Clinical trials for pancreatic cancer are conducted at cancer centers and hospitals in many countries, including the United States, Europe, and other regions. Patients interested in clinical trials can discuss options with their oncology team or contact cancer organizations that maintain databases of available trials. Participation in clinical trials is voluntary, and patients can withdraw at any time.^[13]

Managing Symptoms and Supportive Care

An important aspect of treating pancreatic cancer involves managing symptoms and maintaining quality of life. This is called palliative care or supportive care, and it can be provided alongside treatments aimed at controlling the cancer. The goal is to prevent or relieve symptoms and side effects, address emotional and practical concerns, and help patients and families cope with the disease.^[11]

Pain is a common symptom in pancreatic cancer, particularly when the tumor presses on nerves or other organs. Pain management may involve medications ranging from over-the-counter pain relievers to stronger prescription drugs called opioids. In some cases, procedures that block pain signals from nerves can provide relief. The medical team works to find the right combination of approaches to keep patients comfortable.^[13]

Digestive problems are frequent because the pancreas plays a key role in digestion. When the pancreas is affected by cancer or removed by surgery, patients may not produce enough digestive enzymes. This can lead to difficulty absorbing nutrients, weight loss, and changes in bowel habits. Doctors can prescribe pancreatic enzyme supplements that patients take with meals to help digest food properly.^[13]

If the tumor blocks the bile duct, it can cause jaundice, where the skin and eyes become yellow. This can also cause itching and dark urine. Doctors can place a small tube called a stent in the bile duct to keep it open and allow bile to flow normally, which relieves these symptoms.^[11]

Nutritional support is critical because many pancreatic cancer patients struggle to maintain their weight and strength. Dietitians who specialize in cancer can recommend foods that are easier to digest, suggest eating small frequent meals rather than large ones, and identify nutritional supplements that can help. Good nutrition supports the body’s ability to tolerate treatment and recover from side effects.^[13]

Most Common Treatment Methods

• Surgery
  • Pancreaticoduodenectomy (Whipple procedure) removes the head of the pancreas, part of the small intestine, gallbladder, part of the bile duct, and sometimes part of the stomach
  • Distal pancreatectomy removes the tail and body of the pancreas, often along with the spleen
  • Total pancreatectomy removes the entire pancreas along with connected organs
  • Surgery is the only treatment that offers possibility of cure for pancreatic cancer
  • Only about 20% of patients have surgically removable cancer at diagnosis
• Chemotherapy
  • Gemcitabine interferes with cancer cell DNA replication
  • FOLFIRINOX combines folinic acid, fluorouracil, irinotecan, and oxaliplatin
  • Given in cycles with rest periods to allow body recovery
  • Used as adjuvant therapy after surgery to destroy remaining cancer cells
  • Used as neoadjuvant therapy before surgery to shrink tumors
  • Common side effects include fatigue, nausea, hair loss, and increased infection risk
• Radiation Therapy
  • Uses high-energy beams to damage cancer cell DNA
  • Often combined with chemotherapy as chemoradiation
  • Given five days a week for several weeks
  • Used before surgery to shrink tumors or after surgery to kill remaining cells
  • Can relieve pain and symptoms when cancer cannot be removed
  • Stereotactic body radiation therapy (SBRT) delivers high doses with precision in fewer sessions
• Immunotherapy (in clinical trials)
  • Checkpoint inhibitors block proteins that prevent immune cells from attacking cancer
  • Cancer vaccines train the immune system to recognize specific proteins on cancer cells
  • More likely to work in tumors with specific genetic features
  • Being tested in combination with chemotherapy and targeted therapy
• Targeted Therapy (in clinical trials)
  • Drugs that block specific KRAS mutations found in about 90% of pancreatic cancers
  • Agents that block growth factor receptors on cancer cells
  • Drugs that interfere with blood vessels supplying tumors
  • Treatments targeting DNA repair mechanisms to make cancer cells more vulnerable
  • More selective than chemotherapy, potentially causing fewer side effects
• Palliative and Supportive Care
  • Pain management using medications and nerve block procedures
  • Pancreatic enzyme supplements to help with digestion
  • Stent placement to relieve bile duct blockage and jaundice
  • Nutritional support and dietary counseling
  • Emotional and psychological support services